The China Macao-Shanghai Artificial Intelligence Translational Medicine Center was not too long ago inaugurated on the Macau University of Science and Technology, establishing the primary collaborative platform between Shanghai and Macao devoted to merging AI with translational medication.
The middle, initiated by the Macau University of Science and Technology basis, is collectively established by the Macao Translational Medicine Center, Shanghai Artificial Intelligence Research Institute, and the Global Alliance on Artificial Intelligence for Industry and Manufacturing Center of Excellence.
The middle maintains bases in each Shanghai and Macao, aiming to boost technological coordination between the 2 cities and speed up the transformation of AI research achievements in healthcare.
“This dual-center mechanism represents a breakthrough innovation that harnesses the advantages of Macao and Shanghai to advance human health,” mentioned Hsiang Mei Su, member of the Shanghai Municipal Committee of the CPPCC and director of administration of the Macao Translational Medicine Center. “While Shanghai drives innovation through its AI capabilities, Macao serves as a bridge connecting domestic and international resources while gathering cutting-edge medical research findings.”
Shanghai”s prominence in AI healthcare is substantial, according to Song Haitao, director of Shanghai Artificial Intelligence Research Institute. “Shanghai homes one-third of China’s core AI enterprises, huge medical datasets from premier hospitals, and a complicated biomedical business,” Song mentioned, highlighting town’s superior research infrastructure, together with the National Facility for Translational Medicine (Shanghai).
The institute has shaped a global collaborative community spanning Southeast Asia, the Guangdong-Hong Kong-Macao Greater Bay Area, and the Yangtze River Delta area, forging partnerships with establishments just like the National University of Singapore.
In Macao, the middle builds upon the inspiration of the Macao Translational Medicine Center, established in March 2024. “The collaborative center’s inauguration will catalyze the translation of biomedical research into clinical applications and help overcome development challenges in Traditional Chinese Medicine,” mentioned He Yao, director of the Macao Translational Medicine Center.
“Beyond improving healthcare outcomes, this initiative will contribute to Macao’s economic diversification,” He mentioned, noting the middle’s strategic partnerships with international organizations, together with Springer Nature Group.
Looking forward, the middle goals to determine a global demonstration platform for AI-integrated Chinese and Western medication and develop standardization protocols for TCM. Leveraging Macao’s distinctive function as a connector to Portuguese-speaking nations, the middle additionally plans to advertise Chinese AI medical requirements and develop a multilingual Chinese medication pondering chain corpus.
The inauguration ceremony was attended by Shanghai Mayor Gong Zheng, O Lam, secretary for social affairs and tradition of the Macao SAR Government, and different officers from each areas.